NAGE

Launch of Tru Niagen® Beauty: Niagen Bioscience has introduced Tru Niagen® Beauty, the first beauty supplement in the U.S. featuring Niagen (nicotinamide riboside), aimed at enhancing skin, hair, and nail health through cellular support.

Key Ingredients and Benefits: The supplement contains a blend of clinically studied ingredients, including Astaxanthin, Hyaluronic Acid, Grape Seed Extract, Biotin, and Vitamin E, designed to improve skin hydration, elasticity, and overall beauty from within.

Market Growth Potential: The U.S. astaxanthin market is projected to grow significantly, reflecting increasing consumer demand for natural antioxidants and health supplements, while the global nutricosmetics market is also expected to expand rapidly.

Commitment to Scientific Research: Niagen Bioscience emphasizes its dedication to advancing healthspan through evidence-based innovations and rigorous scientific research, positioning itself as a leader in NAD+ science and healthy aging.

Study Overview: Niagen Biosciences conducted a randomized controlled trial on its nicotinamide riboside (NR) supplement, Niagen, to evaluate its effects on individuals suffering from long COVID symptoms, with 58 participants receiving either the supplement or a placebo.

Results and Findings: While the primary endpoint was not statistically significant, participants taking Niagen NR reported improvements in fatigue, sleep quality, and mood, with NAD+ levels increasing significantly, indicating potential benefits in addressing long COVID.

Safety and Tolerability: The Niagen NR supplement was well tolerated among participants, showing no significant difference in adverse events compared to the placebo group, suggesting a favorable safety profile.

Future Research Plans: Niagen Biosciences aims to further investigate NAD+ biology and its therapeutic potential for post-viral recovery, with plans for larger studies to validate the initial findings from this trial.

Clinical Trial Findings: A clinical trial published in The Lancet showed that daily supplementation with Niagen® significantly increased NAD+ levels and improved symptoms such as fatigue, depression, and sleep quality in individuals with long COVID.

Study Overview: The randomized, double-blind, placebo-controlled study involved 58 participants and demonstrated within-group improvements in cognitive performance and other symptoms, although no statistically significant differences were found between the Niagen and placebo groups.

Importance of NAD+: The study highlights the potential role of NAD+ restoration in addressing long COVID symptoms, suggesting that it may help restore biological pathways affected by the condition, including mitochondrial function and cellular repair.

Future Research Directions: While the findings are promising, further large-scale studies are needed to confirm the results and better understand the therapeutic potential of NAD+ in post-viral recovery and energy metabolism.